Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine

Author: Kant Caroline S   Ibberson Mark R   Scheer Alexander  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.5, Iss.2, 2010-02, pp. : 117-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract